Nerve
Auvelity Approved for Alzheimer Agitation: First Non-Antipsychotic Option
Auvelity approved for Alzheimer agitation: first non-antipsychotic option, offering new treatment for patients and clinicians.
This website is intended for use by healthcare professionals.
Nerve
Auvelity approved for Alzheimer agitation: first non-antipsychotic option, offering new treatment for patients and clinicians.
Stories You Can Use
Minnesota hospitals ranked low in charity care, impacting uninsured patients and healthcare professionals.
Health Industry
HHS pushes hospitals to adopt 2025-30 dietary guidelines for Medicaid, Medicare eligibility
Insurance
Democrats debate single-payer models, but funding remains unclear for healthcare professionals.
Audience Fit
Follow healthcare developments, specialty reporting, guideline context, and topics that affect patient care, operations, reimbursement, and care coordination.
Coverage Explorer
Scan clinical desks by topic, icon, and volume so specialty coverage is easier to compare.
Wellness and support resources for clinical practice.
Dietary pattern explainers, counseling language, and adherence barriers.
Sleep, stress, activity, and coaching frameworks that align with clinical care.
Exercise, conditioning, and return-to-function topics for care planning.
Plain-language resources clinicians can reference or adapt at the point of care.
Clinician Digest
Choose the clinical desks you want to follow and save the preference for future visits.